← Back to Search

Behavioural Intervention

Behavioural Experiments (CBT) for Emotional Disturbance (EC-II-Ado-P Trial)

N/A
Recruiting
Led By Michel J. Dugas, Ph.D.
Research Sponsored by Universite du Quebec en Outaouais
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adolescents aged between 14 and 18 years
Primary diagnosis of Generalized Anxiety Disorder (GAD)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 weeks
Awards & highlights

EC-II-Ado-P Trial Summary

This trial aims to test a new treatment for Generalized Anxiety Disorder (GAD) in adolescents. GAD is a condition where people experience excessive and uncontrollable worry and anxiety. In Canada, around

Who is the study for?
This trial is for adolescents who have been diagnosed with Generalized Anxiety Disorder (GAD). They should be experiencing excessive worry and anxiety that impacts their daily life. The study aims to help those struggling with the uncertainty that comes with GAD.Check my eligibility
What is being tested?
The pilot study tests a new psychological treatment called Behavioural Experiments for Intolerance of Uncertainty in Adolescents (EC-IIA). It focuses on helping participants manage uncertainty to reduce anxiety, rather than avoiding uncertain situations.See study design
What are the potential side effects?
Since this is a psychological intervention focusing on behavior experiments, there are no direct physical side effects like you would expect from medication. However, participants may experience discomfort or increased anxiety when facing uncertain situations during the therapy.

EC-II-Ado-P Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 14 and 18 years old.
Select...
I have been diagnosed with Generalized Anxiety Disorder.
Select...
I am not undergoing psychotherapy during the trial.

EC-II-Ado-P Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Anxiety and Related Disorders Interview Schedule for DSM-5 (ADIS-5)
Secondary outcome measures
Beck Anxiety Inventory (BAI)
Beck Depression Inventory-II (BDI-II)
Penn State Worry Questionnaire (PSWQ)
+1 more
Other outcome measures
Intolerance of Uncertainty Scale (IUS)
Safety Behaviors Questionnaire (SBQ)
Treatment Acceptance and Adherence Scale (TAAS)
+1 more

EC-II-Ado-P Trial Design

1Treatment groups
Experimental Treatment
Group I: Behavioural Experiments (CBT)Experimental Treatment1 Intervention
Behavioural experiments involve selecting a specific thought to test (for example, "uncertainty makes me incapable of acting") and designing a detailed experiment to challenge this thought.

Find a Location

Who is running the clinical trial?

Universite du Quebec en OutaouaisLead Sponsor
12 Previous Clinical Trials
902 Total Patients Enrolled
Michel J. Dugas, Ph.D.Principal InvestigatorUniversite du Quebec en Outaouais
2 Previous Clinical Trials
159 Total Patients Enrolled
~0 spots leftby Jul 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top